The generic developed by Laboratorios Richmond showed that it has similar effectiveness and safety profiles than the original, and a significantly lower cost. The last successful test was a multicenter study that included 321 patients from 15 centers with chronic hepatitis C. (www.lanacion.com.ar)
Laboratorios Richmond was present through its President, Marcelo Figueiras in the first edition of Forbes Healthcare Argentina held on May 10 at the Sheraton Convention Center in Buenos Aires. In his speech on the panel dedicated to the "shift from the pharmaceutical market to biologics," Figueiras said that "the key word in the health industry today is: accessibility, that is, that more people can access the medicines they need."
Laboratorios Richmond, a leading pharmaceutical company and one of the main suppliers of oncological and HIV drugs in Argentina, received more than 1,800 orders for an amount greater than $ 658 MILLION, and will start trading on the Buenos Aires Stock Exchange. The transaction was led by Puente as an organizer and placement agent, together BST (Services and Transactions Bank) that acted as co-placer.
En el marco del 43° Congreso Argentino de Cardiología se presenta el documento conjunto de la Sociedad Argentina de Cardiología (SAC) y de la Federación Argentina de Cardiología (FAC) acerca del rol de la polipíldora (Trinomia) como estrategia de prevención cardiovascular en nuestro país.
As part of the process of constant growth, Laboratorios RICHMOND has inaugurated its new administrative offices in three floors of the building located in Bouchard 680, in downtown Buenos Aires. Thus, it brings together in a single headquarters the Direction, Administration and Finance, Commercialization, International Business, Supplying, Legal Affairs and Human Resources.
Después de casi dos años de trabajo, se presentaron los primeros resultados del Estudio Andes. Se dieron a conocer prometedores avances argentinos en la lucha contra el VIH en un trabajo de la Fundación Huésped con el apoyo de los Ministerios de Ciencia y Tecnología, Salud y de Laboratorios Richmond.
Laboratorios Richmond has announced the launch of TRIVENZ®, the first generic in Argentina with the combination of Efavirenz, Emtricitabine and Tenofovir DF. This product for HIV treatment required the exclusive development of a monolithic tablet to ensure physic-chemical compatibility and bioavailability of the active ingredients.
Reaffirming the commitment to the environment and the community, Laboratorios Richmond obtained its ISO 14001 certification, consolidating its environmental management system under the highest international quality standards.
With the objective of contributing to the professional growth of young people and helping them to integrate into the working world successfully, Laboratorios Richmond adhered to the program that the Municipality of Pilar carries out with students, teachers and authorities of the Technical Schools.
